| The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford LA Herzenberg, D Parks, B Sahaf, O Perez, M Roederer, LA Herzenberg Clinical chemistry 48 (10), 1819-1827, 2002 | 903 | 2002 |
| GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas RG Majzner, S Ramakrishna, KW Yeom, S Patel, H Chinnasamy, ... Nature 603 (7903), 934-941, 2022 | 602 | 2022 |
| Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing SD Boyd, EL Marshall, JD Merker, JM Maniar, LN Zhang, B Sahaf, ... Science translational medicine 1 (12), 12ra23-12ra23, 2009 | 593 | 2009 |
| CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial JY Spiegel, S Patel, L Muffly, NM Hossain, J Oak, JH Baird, MJ Frank, ... Nature medicine 27 (8), 1419-1431, 2021 | 468 | 2021 |
| Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal S Salzano, P Checconi, EM Hanschmann, CH Lillig, LD Bowler, P Chan, ... Proceedings of the National Academy of Sciences 111 (33), 12157-12162, 2014 | 404 | 2014 |
| Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements SD Boyd, BA Gaëta, KJ Jackson, AZ Fire, EL Marshall, JD Merker, ... The Journal of Immunology 184 (12), 6986-6992, 2010 | 353 | 2010 |
| Modern flow cytometry: a practical approach JW Tung, K Heydari, R Tirouvanziam, B Sahaf, DR Parks, LA Herzenberg, ... Clinics in laboratory medicine 27 (3), 453-468, 2007 | 297 | 2007 |
| High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment AC Logan, H Gao, C Wang, B Sahaf, CD Jones, EL Marshall, I Buño, ... Proceedings of the National Academy of Sciences 108 (52), 21194-21199, 2011 | 252 | 2011 |
| Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma A Söderberg, B Sahaf, A Rosén Cancer research 60 (8), 2281-2289, 2000 | 237 | 2000 |
| Lymphocyte surface thiol levels B Sahaf, K Heydari, LA Herzenberg, LA Herzenberg Proceedings of the National Academy of Sciences 100 (7), 4001-4005, 2003 | 191 | 2003 |
| Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy Z Good, JY Spiegel, B Sahaf, MB Malipatlolla, ZJ Ehlinger, S Kurra, ... Nature medicine 28 (9), 1860-1871, 2022 | 155 | 2022 |
| Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma JH Baird, DJ Epstein, JS Tamaresis, Z Ehlinger, JY Spiegel, J Craig, ... Blood advances 5 (1), 143-155, 2021 | 155 | 2021 |
| GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity S Heitzeneder, KR Bosse, Z Zhu, D Zhelev, RG Majzner, MT Radosevich, ... Cancer Cell 40 (1), 53-69. e9, 2022 | 129 | 2022 |
| Comprehensive immune monitoring of clinical trials to advance human immunotherapy FJ Hartmann, J Babdor, PF Gherardini, EAD Amir, K Jones, B Sahaf, ... Cell reports 28 (3), 819-831. e4, 2019 | 121 | 2019 |
| Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence S Arai, B Sahaf, B Narasimhan, GL Chen, CD Jones, R Lowsky, ... Blood, The Journal of the American Society of Hematology 119 (25), 6145-6154, 2012 | 121 | 2012 |
| Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT CE Ryan, B Sahaf, AC Logan, S O’Brien, JC Byrd, P Hillmen, JR Brown, ... Blood, The Journal of the American Society of Hematology 128 (25), 2899-2908, 2016 | 95 | 2016 |
| Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species B Sahaf, A Söderberg, G Spyrou, AM Barral, K Pekkari, A Holmgren, ... Experimental cell research 236 (1), 181-192, 1997 | 95 | 1997 |
| Clinical impact of HY alloimmunity R Popli, B Sahaf, H Nakasone, JYY Lee, DB Miklos Immunologic research 58, 249-258, 2014 | 89 | 2014 |
| Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas BJ Sworder, DM Kurtz, SK Alig, MJ Frank, N Shukla, A Garofalo, ... Cancer cell 41 (1), 210-225. e5, 2023 | 83 | 2023 |
| The extracellular microenvironment plays a key role in regulating the redox status of cell surface proteins in HIV-infected subjects B Sahaf, K Heydari, LA Herzenberg, LA Herzenberg Archives of biochemistry and biophysics 434 (1), 26-32, 2005 | 82 | 2005 |